Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.

Durkan, G C; Nutt, J E; Rajjayabun, P H; Neal, D E; Lunec, J; Mellon, J K

Durkan, G C; Nutt, J E; Rajjayabun, P H; Neal, D E; Lunec, J; Mellon, J K.

Affiliation

Durkan GC; Department of Surgery, Cancer Research Unit, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, United Kingdom.

Clin Cancer Res ; 7(11): 3450-6, 2001 Nov.

Article in En | MEDLINE | ID: mdl-11705862

Subject(s)

Carcinoma, Transitional Cell/pathology; Matrix Metalloproteinase 1/urine; Tissue Inhibitor of Metalloproteinase-1/urine; Urinary Bladder Neoplasms/pathology; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell/urine; Disease Progression; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Urinary Bladder Neoplasms/urine

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Tissue Inhibitor of Metalloproteinase-1 / Matrix Metalloproteinase 1 Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links